Pablo de la Cueva ha participado como asesor y/o investigador y/o ponente con los siguientes laboratorios farmacuticos: Abbvie, Almirall, BMS, Boehringer-Ingelheim, Celgene, Janssen Cilag, LEO Pharma, Lilly, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi y UCB
P = 0.22] or plasma [Standardized Mean Difference: 0.44, 95% CI (-0.21, 1.09)
Do not use if contraindicated: For example, Zepbound has a boxed warning for thyroid C-cell tumors observed in rats and lists contraindication in patients with a personal or family history of medullary thyroid carcinoma or MEN2
We therefore hypothesise that the GLP-1R-dependent phosphorylation of MIC19 at ERMCSs might not only highlight a direct role for the receptor in the control of mitochondrial dynamics, but also regulate lipid precursor transfer across ERMCSs to sustain mitochondrial turnover
Cellspecific protein kinase A activation enhances the efficiency of glucose control by increasing acutephase insulin secretion